Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.490
+0.100 (7.19%)
Nov 22, 2024, 4:00 PM EST - Market closed
Evaxion Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 4.58 | 5.58 | 13.18 | 32.17 | 5.83 | 9.56 | Upgrade
|
| Cash & Short-Term Investments | 4.58 | 5.58 | 13.18 | 32.17 | 5.83 | 9.56 | Upgrade
|
| Cash Growth | 75.66% | -57.65% | -59.01% | 451.35% | -38.97% | 28.60% | Upgrade
|
| Other Receivables | - | 1.08 | 1.31 | 1.9 | 2.21 | 0.93 | Upgrade
|
| Receivables | - | 1.08 | 1.31 | 1.9 | 2.21 | 0.93 | Upgrade
|
| Prepaid Expenses | - | 1.69 | 2.49 | 0.64 | 1.18 | 0.47 | Upgrade
|
| Other Current Assets | - | - | - | - | 1.73 | - | Upgrade
|
| Total Current Assets | 4.58 | 8.35 | 16.99 | 34.71 | 10.95 | 10.96 | Upgrade
|
| Property, Plant & Equipment | - | 4.34 | 4.68 | 5.17 | 0.22 | 0.1 | Upgrade
|
| Other Intangible Assets | - | - | - | 0.09 | 0.1 | - | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 0.26 | - | Upgrade
|
| Other Long-Term Assets | 10.61 | 0.2 | 0.37 | 0.19 | 0.43 | 0.03 | Upgrade
|
| Total Assets | 15.19 | 12.89 | 22.03 | 40.16 | 11.97 | 11.08 | Upgrade
|
| Accounts Payable | - | 2.69 | 2.09 | 2.85 | 3.67 | 0.65 | Upgrade
|
| Accrued Expenses | - | 0.89 | 0.35 | 0.99 | 1.05 | 0.86 | Upgrade
|
| Current Portion of Long-Term Debt | - | 0.16 | 0.14 | 0.13 | - | - | Upgrade
|
| Current Portion of Leases | - | 0.33 | 0.3 | 0.31 | 0.02 | 0.04 | Upgrade
|
| Other Current Liabilities | - | 3.02 | 0.89 | 0.05 | 0.18 | 0.18 | Upgrade
|
| Total Current Liabilities | - | 7.08 | 3.76 | 4.32 | 4.93 | 1.72 | Upgrade
|
| Long-Term Debt | - | 8.49 | 7.86 | 1.04 | - | - | Upgrade
|
| Long-Term Leases | - | 1.9 | 1.95 | 2.21 | - | - | Upgrade
|
| Other Long-Term Liabilities | 15.11 | 0.15 | 0.14 | 0.15 | - | - | Upgrade
|
| Total Liabilities | 15.11 | 17.62 | 13.72 | 7.73 | 4.93 | 1.72 | Upgrade
|
| Common Stock | 8.73 | 5.9 | 3.89 | 3.76 | 2.65 | 2.48 | Upgrade
|
| Additional Paid-In Capital | - | 87.45 | 80.73 | 80.43 | 31.44 | 22.86 | Upgrade
|
| Retained Earnings | -114.9 | -107.97 | -85.85 | -50.43 | -27.28 | -15.81 | Upgrade
|
| Comprehensive Income & Other | 106.25 | 9.89 | 9.54 | -1.32 | 0.23 | -0.17 | Upgrade
|
| Shareholders' Equity | 0.07 | -4.73 | 8.3 | 32.44 | 7.04 | 9.36 | Upgrade
|
| Total Liabilities & Equity | 15.19 | 12.89 | 22.03 | 40.16 | 11.97 | 11.08 | Upgrade
|
| Total Debt | - | 10.87 | 10.26 | 3.69 | 0.02 | 0.04 | Upgrade
|
| Net Cash (Debt) | 4.58 | -5.29 | 2.93 | 28.48 | 5.81 | 9.52 | Upgrade
|
| Net Cash Growth | - | - | -89.71% | 389.78% | -38.95% | - | Upgrade
|
| Net Cash Per Share | 0.99 | -1.93 | 1.24 | 14.61 | 3.77 | 6.85 | Upgrade
|
| Filing Date Shares Outstanding | 5.53 | 5.22 | 2.41 | 2.32 | 1.92 | 1.59 | Upgrade
|
| Total Common Shares Outstanding | 5.53 | 3.79 | 2.41 | 2.32 | 1.62 | 1.52 | Upgrade
|
| Working Capital | 4.58 | 1.27 | 13.22 | 30.38 | 6.02 | 9.24 | Upgrade
|
| Book Value Per Share | 0.01 | -1.25 | 3.44 | 13.98 | 4.34 | 6.17 | Upgrade
|
| Tangible Book Value | 0.07 | -4.73 | 8.3 | 32.34 | 6.94 | 9.36 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | -1.25 | 3.44 | 13.94 | 4.28 | 6.17 | Upgrade
|
| Machinery | - | 1.44 | 1.37 | 1.23 | 0.26 | 0.09 | Upgrade
|
| Leasehold Improvements | - | 1.75 | 1.63 | 1.57 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.